Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog.
Sakura KirinoNobuharu TamakiShun KanekoMasayuki KurosakiKento InadaKoji YamashitaLeona OsawaYuka HayakawaShuhei SekiguchiKeiya WatakabeMao OkadaWan WangTakao ShimizuMayu HiguchiKenta TakauraChiaki MaeyashikiYutaka YasuiHiroyuki NakanishiKaoru TsuchiyaJun ItakuraYuka TakahashiNamiki IzumiPublished in: Journal of gastroenterology and hepatology (2020)
PAGE-B, which can easily identify high-risk cases, can be useful for predicting HCC development in Japanese patients treated with NA therapy.